Primovist Regulatory Post Marketing Surveillance (PMS)
NCT00924248 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4358
Last updated 2012-09-19
Summary
The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice
Conditions
- Liver
Interventions
- DRUG
-
Gadoxetic acid disodium (Primovist, BAY86-4873)
Patients in daily life clinical practice treatment receiving Primovist according to indication on the label.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-10-31
- Completion
- 2011-05-31
Countries
- South Korea
More Related Trials
-
Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B
NCT02533544 ·Status: COMPLETED
-
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
NCT01590654 ·Status: COMPLETED ·Phase: PHASE1
-
Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection
NCT01594905 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy
NCT02868242 ·Status: COMPLETED ·Phase: PHASE2
-
A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo
NCT03642340 ·Status: UNKNOWN
-
Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation
NCT00065507 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection
NCT03186313 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
NCT01590641 ·Status: COMPLETED ·Phase: PHASE1
-
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
NCT00704106 ·Status: COMPLETED
-
HEPSERA Post Marketing Surveillance
NCT01329419 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine
NCT04289987 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection
NCT02981602 ·Status: COMPLETED ·Phase: PHASE2
-
Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients
NCT00823550 ·Status: UNKNOWN ·Phase: PHASE4
-
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Treated Patients With Chronic Hepatitis B
NCT07190742 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group
NCT00313261 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients
NCT05957380 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients
NCT00798460 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment
NCT02174276 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
NCT07024641 ·Status: RECRUITING ·Phase: PHASE1
-
Study To Evaluate Safety and Efficacy of Vesatolimod for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Participants
NCT02166047 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection
NCT00393484 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B
NCT01026610 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection
NCT02613871 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα
NCT01694264 ·Status: TERMINATED ·Phase: PHASE3
-
A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B
NCT06150014 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2